CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...

Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

With a solid foundation for growth and a promising outlook, the global lancet market is on track to achieve its projected USD ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

A CGM helps me run marathons and do epic bike rides better than ever.

Abbott has won an innovation award for Lingo, its first consumer biowearable over-the-counter device that helps people ...

Abbott reported fourth-quarter results that missed the consensus sales forecast — but medical device sales remain a bright ...